Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Matthew O'Brien's Stock Ratings
Piper Sandler Analyst
Matthew O'Brien is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/21/2025
Overall Average Return
10.1%
Smart Score
Overall Average Return Percentile
61st
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 07/01/2024 | ZBH | Buy Now | Zimmer Biomet Holdings | $93.51 | 22.98% | Matthew O'Brien64% | $140 → $115 | Downgrade | Overweight → Neutral | Get Alert |
| 05/08/2024 | ATEC | Buy Now | Alphatec Holdings | $12.89 | 31.89% | Matthew O'Brien64% | $19 → $17 | Maintains | Overweight | Get Alert |
| 01/05/2023 | ZBH | Buy Now | Zimmer Biomet Holdings | $93.51 | 39.02% | Matthew O'Brien64% | $120 → $130 | Maintains | Neutral | Get Alert |
| 08/02/2022 | ZBH | Buy Now | Zimmer Biomet Holdings | $93.51 | 28.33% | Matthew O'Brien64% | $130 → $120 | Maintains | Neutral | Get Alert |
| 05/03/2022 | ZBH | Buy Now | Zimmer Biomet Holdings | $93.51 | 39.02% | Matthew O'Brien64% | $110 → $130 | Maintains | Neutral | Get Alert |
| 03/14/2022 | SPNE | Buy Now | SeaSpine Holdings | — | — | Matthew O'Brien64% | $28 → $21 | Maintains | Overweight | Get Alert |
| 03/02/2022 | ATEC | Buy Now | Alphatec Holdings | $12.89 | 31.89% | Matthew O'Brien64% | $22 → $17 | Maintains | Overweight | Get Alert |
| 02/24/2022 | PODD | Buy Now | Insulet | $326.36 | -29.53% | Matthew O'Brien64% | $295 → $230 | Maintains | Neutral | Get Alert |
| 02/07/2022 | ZBH | Buy Now | Zimmer Biomet Holdings | $93.51 | 17.63% | Matthew O'Brien64% | $135 → $110 | Maintains | Neutral | Get Alert |
| 01/26/2021 | KRMD | Buy Now | KORU Medical Systems | $2.87 | 56.79% | Matthew O'Brien64% | $9 → $4.5 | Downgrade | Overweight → Neutral | Get Alert |
| 01/08/2021 | ZBH | Buy Now | Zimmer Biomet Holdings | $93.51 | 97.84% | Matthew O'Brien64% | $160 → $185 | Maintains | Overweight | Get Alert |
| 11/05/2020 | ZBH | Buy Now | Zimmer Biomet Holdings | $93.51 | 71.1% | Matthew O'Brien64% | → $160 | Maintains | Overweight | Get Alert |
| 11/02/2020 | AZYO | Buy Now | Aziyo Biologics | — | — | Matthew O'Brien64% | → $20 | Initiates | → Overweight | Get Alert |
| 10/29/2020 | IART | Buy Now | Integra Lifesciences | $13.27 | 254.18% | Matthew O'Brien64% | $53 → $47 | Maintains | Neutral | Get Alert |
| 09/21/2020 | ZBH | Buy Now | Zimmer Biomet Holdings | $93.51 | 71.1% | Matthew O'Brien64% | → $160 | Maintains | Overweight | Get Alert |
| 08/04/2020 | ZBH | Buy Now | Zimmer Biomet Holdings | $93.51 | 71.1% | Matthew O'Brien64% | → $160 | Maintains | Overweight | Get Alert |
| 05/11/2020 | ZBH | Buy Now | Zimmer Biomet Holdings | $93.51 | 71.1% | Matthew O'Brien64% | $175 → $160 | Maintains | Overweight | Get Alert |
| 01/07/2020 | IART | Buy Now | Integra Lifesciences | $13.27 | 337.08% | Matthew O'Brien64% | $59 → $58 | Downgrade | Overweight → Neutral | Get Alert |
| 01/07/2020 | ZBH | Buy Now | Zimmer Biomet Holdings | $93.51 | 81.8% | Matthew O'Brien64% | $140 → $170 | Upgrade | Neutral → Overweight | Get Alert |
| 08/05/2019 | ATEC | Buy Now | Alphatec Holdings | $12.89 | -45.69% | Matthew O'Brien64% | → $7 | Initiates | → Overweight | Get Alert |
| 07/27/2018 | BAX | Buy Now | Baxter Intl | $30.70 | 170.36% | Matthew O'Brien64% | $77 → $83 | Maintains | Overweight | Get Alert |
| 05/24/2018 | ALGN | Buy Now | Align Tech | $177.88 | 82.7% | Matthew O'Brien64% | $300 → $325 | Maintains | Overweight | Get Alert |
| 03/12/2018 | MOTS | Buy Now | Motus GI Hldgs | $0.00 | 2333233.33% | Matthew O'Brien64% | → $7 | Initiates | → Overweight | Get Alert |
| 11/02/2017 | ZBH | Buy Now | Zimmer Biomet Holdings | $93.51 | — | Matthew O'Brien64% | — | Downgrade | Overweight → Neutral | Get Alert |
| 05/22/2017 | DXCM | Buy Now | DexCom | $85.65 | -8.93% | Matthew O'Brien64% | → $78 | Reinstates | → Overweight | Get Alert |
| 04/06/2017 | ABMD | Buy Now | Abiomed | — | — | Matthew O'Brien64% | — | Upgrade | Neutral → Overweight | Get Alert |
| 03/03/2017 | MDXG | Buy Now | MiMedx Group | $7.10 | 40.85% | Matthew O'Brien64% | → $10 | Initiates | → Overweight | Get Alert |
| 07/02/2015 | SPNE | Buy Now | SeaSpine Holdings Corporation - Common Stock | — | — | Matthew O'Brien64% | → $24 | Initiates | → Overweight | Get Alert |
| 03/10/2015 | IART | Buy Now | Integra Lifesciences | $13.27 | 404.9% | Matthew O'Brien64% | → $67 | Initiates | → Overweight | Get Alert |
| 08/15/2013 | IART | Buy Now | Integra Lifesciences | $13.27 | 276.79% | Matthew O'Brien64% | $41 → $50 | Upgrade | Neutral → Overweight | Get Alert |
| 04/11/2013 | IART | Buy Now | Integra Lifesciences | $13.27 | 208.97% | Matthew O'Brien64% | $46 → $41 | Maintains | Neutral | Get Alert |
| 04/09/2013 | ABMD | Buy Now | Abiomed | — | — | Matthew O'Brien64% | → $18 | Downgrade | Overweight → Neutral | Get Alert |
| 02/22/2013 | IART | Buy Now | Integra Lifesciences | $13.27 | 246.65% | Matthew O'Brien64% | $43 → $46 | Maintains | Neutral | Get Alert |
| 07/30/2012 | IART | Buy Now | Integra Lifesciences | $13.27 | 208.97% | Matthew O'Brien64% | $40 → $41 | Maintains | Neutral | Get Alert |
| 05/17/2012 | ABMD | Buy Now | Abiomed | — | — | Matthew O'Brien64% | $25 → $27 | Maintains | Overweight | Get Alert |
| 02/24/2012 | IART | Buy Now | Integra LifeSciences Holdings | $13.27 | 156.22% | Matthew O'Brien64% | $35 → $34 | Maintains | Neutral | Get Alert |
